Johnson & Johnson vaccine fears: US recommends ‘pause’ to jab rollout after blood clots

When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.

US federal health agencies have recommended pausing the use of Johnson & Johnson’s single-dose Covid vaccine after six recipients developed a rare disorder involving blood clots. The US Centers for Disease Control and Prevention will hold an advisory meeting on Wednesday to review the cases. The US Food and Drug Administration sought to reassure the public that the side effects “appear to be extremely rare”. 


Source: Read Full Article